View of Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir | Drug Target Insights

Return to Article Details Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir